tiprankstipranks
Trending News
More News >
Simcere Pharmaceutical Group Limited (HK:2096)
:2096
Hong Kong Market

Simcere Pharmaceutical Group Limited (2096) Income Statement

Compare
4 Followers

Simcere Pharmaceutical Group Limited Income Statement

Last quarter (Q4 2024), Simcere Pharmaceutical Group Limited's total revenue was ¥1.76B, an increase of 9.08% from the same quarter last year. In Q4, Simcere Pharmaceutical Group Limited's net income was ¥138.28M. See Simcere Pharmaceutical Group Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 6.64B¥ 6.61B¥ 6.32B¥ 5.00B¥ 4.51B
Gross Profit
¥ 5.32B¥ 4.98B¥ 5.00B¥ 3.92B¥ 3.61B
Operating Expenses
¥ 4.48B¥ 4.27B¥ 4.42B¥ 3.70B¥ 3.02B
Depreciation and Amortization
¥ 214.29M¥ 309.59M¥ 283.65M¥ 251.81M¥ 222.33M
EBITDA
¥ 1.35B¥ 1.08B¥ 1.09B¥ 939.71M¥ 787.99M
Operating Income
¥ 848.05M¥ 711.80M¥ 862.50M¥ 687.90M¥ 565.66M
Other Income/Expenses
¥ -28.17M¥ 28.24M¥ 25.65M¥ -46.75M¥ -121.75M
Pretax Income
¥ 819.88M¥ 740.04M¥ 888.15M¥ 1.40B¥ 805.09M
Net Income
¥ 733.16M¥ 714.76M¥ 930.87M¥ 1.51B¥ 669.53M
Per Share Metrics
Basic EPS
¥ 0.29¥ 0.27¥ 0.40¥ 0.58¥ 0.26
Diluted EPS
¥ 0.29¥ 0.27¥ 0.40¥ 0.58¥ 0.26
Weighted Average Shares Outstanding
2.53B 2.65B 2.61B 2.61B 2.61B
Weighted Average Shares Outstanding (Diluted)
2.52B 2.61B 2.62B 2.61B 2.61B
Currency in CNY

Simcere Pharmaceutical Group Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis